Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes

Hypertension

Volumn 27, Issue 5, 1996, Pages 1134-1139

  Doria, Alessandro ^b   Onuma, Tomio ^b   Gearin, Gary ^b   Beatriz, M ^b   Freire, S ^b   Warram, James H ^b   Krolewski, Andrzej S ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

angiotensinogen; genetics; insulin dependent diabetes; nephropathy

Indexed keywords

ANGIOTENSINOGEN;

ADOLESCENT; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA DETERMINATION; ESSENTIAL HYPERTENSION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT;

EID: 0029933535     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.5.1134     Document Type: Article

References (35)

1. Krolewski AS, Warram JH. Epidemiology of late complications of diabetes. In: Kahn CR, Weir G, eds. Joslin's Diabetes Mellitus. 13th ed. Philadelphia, Pa: Lea & Febiger; 1994:605-619.
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiologic study. Diabetologia. 1983;25:496-501.
3. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH. Glycated hemoglobin and risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;332: 1252-1255.
4. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1995; 329:977-986.
5. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985;78:785-794.
6. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320:1161-1165.
7. Borch-Johnsen K, Nørgaard K, Hommel E, Mathinesen ER, Jensen JS, Deckert T, Parving HH. Is diabetic nephropathy an inherited complication? Kidney Int. 1992;41:719-722.
8. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. In press.
9. Doria A, Warram JH, Krolewski AS. Genetic susceptibility to nephropathy in IDDM: from epidemiology to molecular genetics. Diabetes Metab Rev. 1995;11:287-314.
10. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J. 1987; 295:515-517.
11. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med. 1988;318:140-145.
12. Mangili R, Bending JJ, Scott G, Li K, Gupta A, Viberti GC. Increased sodium-lithium countertransport activity in red blood cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med. 1988;318:146-150.
13. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int. 1992;41:723-730.
14. Jensen JS, Mathiesen ER, Norgaard K, Hommel E, Borch-Johnsen K, Funder J, Brahm J, Parving HH, Deckert T. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia. 1990;33: 619-624.
15. Elving LD, Wetzels JFM, DcPont JJHHM, Berden JHM. Is increased sodium-lithium countertransport a useful marker for diabetic nephropathy? Kidney Int. 1992;41:862-871.
16. Doria A, Warram JH, Krolewski AS. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes. 1994;43:690-695.
17. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications. Diabetes. 1994;43: 384-388.
18. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme and human essential hypertension. Nat Genet. 1992;1:72-75.
19. Schmidt S, Schone N, Ritz E, and the Diabetic Nephropathy Study Group. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int. 1995;47:1176-1181.
20. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 1995;44:489-494.
21. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
22. Caulfield M, Lavender P, Farral M, Path MRC, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
23. Ballerman BJ, Zeidel ML, Gunning ME, Brenner BM. Vasoactive peptides and the kidney. In: Brenner BM, Rector FC, eds. The Kidney. 4th ed. Philadelphia. Pa: WB Saunders: 1991:510-583.
24. Caulfield M, Lavender P, Newell-Price J, Farral M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clack AJL. Linkage of the angiotensinogen gene locus to essential hypertension in African Caribbeans. J Clin Invest. 1995;96:687-692.
25. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of IDDM on the prevalence of stages of diabetic nephropathy denned by urinary albumin creatinine ratio. J Am Sac Nephrol. In press.
26. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
27. Parker S, Angelico MC, Laffel L, Krolewski AS. Application of denaturing gradient gel electrophoresis to detect DNA sequence differences encoding apolipoprotein E isoforms. Genomics. 1993; 16:245-247.
28. Behrens J, Warram JH, Lerman LS, Krolewski AS. User-friendly PC program to obtain DNA melting map. Am J Hum Genet. 1990; 47(suppl 1):A173. Abstract.
29. Fischer SG, Lerman LS. DNA fragments differing by single base-pair substitution are separated in denaturing gradient gel: corre- spondence with melting theory. Proc Natl Acad Sci U S A. 1983;80: 1579-1583.
30. Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown & Co; 1986:85-114.
31. Fogarty DO, Harron JC, Hughes AE, Doherty CC, Maxwell AP. The association of an angiolensinogen gene variant with diabetic nephropathy. J Am Soc Nephrol. 1996;6:449. Abstract.
32. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 1994;93:1285-1287.
33. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradely RF, Kahn CR. Magnitude and determinants of coronary artery disease in juvenileonset insulin-dependent diabetes mellitus. Am J Cardiol. 1987;59: 750-755.
34. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin dependent patients. N Engl J Med. 1984;311:89-93.
35. Nibu Y, Takahashi S, Tanimoto K, Murakami K, Fukamizu A. Identification of a cell-type dependent enhancer core element located in the 3′-downstream region of the human angiotensinogen gene. J Biol Chum. 1994;269:2S598-28605.